Routine immunization (RI) is an important tool for child survival and to achieve Millennium Development Goal 4.
Coverage with third dose of diphtheria, tetanus and pertussis vaccine (DTP3) is an accepted global indicator for RI program performance. In India, DPT3 coverage was 72% (WHO-SEARO, EPI Fact Sheet, India 2011) against a global target of 90%.
The WHO Country Office for India provides technical support to the Government of India for strengthening RI at the national, state and district levels.
Support for RI is prioritized and aligned with the WHO Country Cooperation Strategy (2012-17) and Government of India’s draft Multi-Year Strategic Plan (MYP) for the Universal Immunization Programme (UIP) [2012–17]. National support involves developing policy guidelines, formulating the cMYP, preparing training materials and guidelines for RI and new and under-utilized vaccines, facilitating capacity building of healthcare providers and monitoring and surveillance for Adverse Events Following Immunization (AEFI) and Vaccine Preventable Diseases (VPD). In addition, WHO supports review of the UIP, evaluation of trainings and introduction of new vaccines in RI.